CAS No.103628-48-4,Sumatriptan succinate Suppliers,MSDS download

Products Categories

Pharmaceutical (136)
Others (44)
Organic Chemicals (17)
Reagent (3)
Materials (3)
Agrochemicals (3)
(1)
Plant Extract (1)

Basic Information

Molecular Structure:
CAS No.:	103628-48-4
Name:	Sumatriptan succinate
Article Data:	7

Formula:	C₁₈H₂₇N₃O₆S
Molecular Weight:	413.495
Synonyms:	Sumatriptan Alginate;1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide succinate;3-(2-(Dimethylamino)ethyl)-N-methylindole-5-methanesulfonamide succinate (1:1);Antibet;Arcoiran;Diletan;GR 43175C;Imigran;
EINECS:	600-463-4
Density:	1.243 g/cm³
Melting Point:	165-166°C
Boiling Point:	497.7 °C at 760 mmHg
Flash Point:	254.8 °C
Appearance:	white powder
Hazard Symbols:	Xi
Risk Codes:	36/37/38
Safety:	26-36
PSA:	148.18000
LogP:	2.72870

Synthetic route

: 103628-46-2
sumatripan

: 103628-48-4
sumatriptan succinate

Conditions

Conditions	Yield
With succinic acid In acetone at 25 - 35℃; for 1 - 2h; Heating / reflux;
With succinic acid In dichloromethane at 25 - 35℃; for 1 - 1.5h; Heating / reflux;
With succinic acid In ethyl acetate at 25 - 35℃; for 1 - 2h; Heating / reflux;

: 110-15-6
succinic acid

: 103628-46-2
sumatripan

: 103628-48-4
sumatriptan succinate

Conditions

Conditions	Yield
Stage #1: succinic acid; sumatripan In water; acetonitrile for 0.25 - 0.5h; Heating / reflux; Stage #2: In cyclohexane at 25 - 35℃; for 1 - 2h;
In acetone for 2h; Purification / work up; Heating / reflux;
In dichloromethane for 4h; Purification / work up; Heating / reflux;

: 103628-48-4
sumatriptan succinate

: 103628-46-2
sumatripan

Conditions

Conditions	Yield
With sodium hydrogencarbonate In water

Raw Materials

110-15-6

103628-46-2

Downstream Products

103628-46-2

Total:163 Page 1 of 5 1 2 3 4 5 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 103628-48-4

Specification

The Sumatriptan succinate with CAS registry number of 103628-48-4 is also known as 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide succinate. The IUPAC name is Butanedioic acid; 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide. It belongs to product categories of Indoles and derivatives; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Sumatriptan; Serotonin receptor. In addition, the formula is C₁₈H₂₇N₃O₆S and the molecular weight is 413.49. This chemical is a white crystalline powder and it is used as a serotonin 5HT1-receptor agonist.

Physical properties about Sumatriptan succinate are: (1)ACD/LogP: 0.67; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -2.35; (4)ACD/LogD (pH 7.4): -1.21; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 5; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 5; (12)Flash Point: 254.8 °C; (13)Enthalpy of Vaporization: 76.57 kJ/mol; (14)Boiling Point: 497.7 °C at 760 mmHg; (15)Vapour Pressure: 4.83E-10 mmHg at 25 °C.

Preparation of Sumatriptan succinate: it is prepared by reaction of 4-hydrazino-N-methyl, benzyl sulfonamide hydrochloride and 4,4-dimethoxy-N, N-dimethyl-butylamine. The reaction needs catalysts polyphosphoric acid and sodium dihydrogen phosphate. Isopropyl ether and acetone are used as the recrystallization solvents. At last, product is obtained by condensation, rearrangement, cyclization. The yield is about 12.7%.

When you are using this chemical, please be cautious about it. As a chemical, it is irritating to eyes, respiratory system and skin. During using it, wear suitable protective clothing. If contact with eyes accidently, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
1. Canonical SMILES: CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O
2. InChI: InChI=1S/C14H21N3O2S.C4H6O4/c1-15-20(18,
19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;5-3(6)1-2-4(7)8/h4-5,8-9,
15-16H,6-7,10H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
3. InChIKey: PORMUFZNYQJOEI-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD	oral	> 700mg/kg (700mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2065, 1993.
dog	LD	subcutaneous	> 140mg/kg (140mg/kg)	BEHAVIORAL: TREMOR GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2065, 1993.
rat	LD50	intravenous	43112ug/kg (43.112mg/kg)	LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LIVER: OTHER CHANGES	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2059, 1993.
rat	LD50	oral	> 2939mg/kg (2939mg/kg)	BEHAVIORAL: TREMOR LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2059, 1993.
rat	LD50	subcutaneous	1680mg/kg (1680mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: CYANOSIS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2059, 1993.